ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 749

$522K Total Retail Price of All Prescriptions

Rank: 140 out of 749

515 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 515 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 10,925 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 602 550 1 5
LEVOTHYROXINE SODIUM 482 448 2 13
METFORMIN HCL 476 447 3 22
OMEPRAZOLE 452 389 4 6
AMLODIPINE BESYLATE 316 291 5 1
FUROSEMIDE 283 243 6 2
BENAZEPRIL HCL 276 248 7 23
LISINOPRIL 272 265 8 4
METOPROLOL TARTRATE 261 215 9 7
DICLOFENAC SODIUM 254 237 10 166
ATORVASTATIN CALCIUM 247 234 11 18
GABAPENTIN 228 192 12 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 227 205 13 164
LOVASTATIN 223 212 14 52
GLIPIZIDE 217 197 15 32
HYDROCHLOROTHIAZIDE 217 191 15 27
ZOLPIDEM TARTRATE 201 187 17 24
WARFARIN SODIUM 194 194 18 31
ATENOLOL 191 175 19 20
PANTOPRAZOLE SODIUM 156 153 20 30
ALLOPURINOL 152 131 21 10
AZITHROMYCIN 144 121 22 65
TAMSULOSIN HCL 141 131 23 29
LOSARTAN POTASSIUM 140 122 24 9
HYDROCODONE-ACETAMINOPHEN 118 105 S3 25 12
GLYBURIDE-METFORMIN HCL 117 117 R 26 109
PRAVASTATIN SODIUM 114 106 27 49
CARVEDILOL 109 87 28 11
ALENDRONATE SODIUM 108 102 29 40
TRIAMTERENE-HCTZ 105 105 30 77
PROSOL 104 104 31 48
CLONIDINE HCL 103 90 32 15
GLYBURIDE 101 101 R 33 103
ENALAPRIL MALEATE 95 83 34 62
DIOVAN HCT 94 94 35 68
TRAMADOL HCL 94 89 35 47
ISOSORBIDE MONONITRATE ER 90 86 37 45
CIPROFLOXACIN HCL 89 81 38 84
TRIAMCINOLONE ACETONIDE 89 83 38 85
MELOXICAM 88 86 40 78
JANUVIA 83 73 41 33
POTASSIUM CHLORIDE 83 69 41 37
PAROXETINE HCL 82 65 43 122
NEXIUM 79 79 44 34
FINASTERIDE 71 69 45 131
FAMOTIDINE 69 55 46 35
IBUPROFEN 67 57 47 118
ACTOS 64 60 48 70
DIOVAN 64 61 48 14
DONEPEZIL HCL 63 63 50 55
KETOCONAZOLE 61 56 51 370
LIPITOR 60 57 52 71
CLOPIDOGREL 58 41 53 42
METOCLOPRAMIDE HCL 57 55 54 74
NIFEDIPINE ER 55 48 55 21
DOXAZOSIN MESYLATE 54 54 56 38
INSULIN SYRINGE 52 33 57 41
CELEBREX 52 51 57 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.